HTA34 Cost-Effectiveness Analysis of Icosapent Ethyl (IPE) for the Reduction of the Severe Hypertriglyceridemia (HTG) in China
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1385
https://www.valueinhealthjournal.com/article/S1098-3015(24)01500-6/fulltext
Title :
HTA34 Cost-Effectiveness Analysis of Icosapent Ethyl (IPE) for the Reduction of the Severe Hypertriglyceridemia (HTG) in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01500-6&doi=10.1016/j.jval.2024.03.1385
First page :
Section Title :
Open access? :
No
Section Order :
10772